Development Level

Tbio 1 | 10,625
Tchem 1 | 1,890

IMPC Term

abnormal behavior 1 | 226

Disease

Rheumatoid Arthritis 2 | 1,160
acute quadriplegic myopathy 2 | 1,157
atypical teratoid / rhabdoid tumor 2 | 4,369
breast carcinoma 2 | 1,614
glioblastoma 2 | 5,572
group 4 medulloblastoma 2 | 1,875
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
ovarian cancer 2 | 8,484
pancreatic cancer 2 | 2,300
pituitary cancer 2 | 1,972
psoriasis 2 | 6,685
Alzheimer's disease 1 | 644
Amyotrophic Lateral Sclerosis 1 | 431
Arthritis 1 | 248
Atopic dermatitis 1 | 944
Bacteriuria 1 | 13
Becker muscular dystrophy 1 | 187
Brain Ischemia 1 | 87
Brain disease 1 | 83
Bursitis 1 | 10
Cancer 1 | 2,346
Cherubism 1 | 14
Colonic Neoplasms 1 | 126
Duchenne muscular dystrophy 1 | 602
Ectopic pregnancy 1 | 16
Endocarditis 1 | 18
Eye disease 1 | 55
Heart disease 1 | 279
Heat Stroke 1 | 12
Hemangiosarcoma 1 | 18
Hyperglycemia 1 | 120
Intestinal Polyps 1 | 5
Juvenile arthritis 1 | 124
Kidney disease 1 | 396
Liver carcinoma 1 | 217
Liver disease 1 | 219
Liver neoplasms 1 | 109
Lung Neoplasms 1 | 171
Lung disease 1 | 132
Mammary Neoplasms 1 | 410
Mercury Poisoning, Nervous System 1 | 1
Neoplastic Cell Transformation 1 | 81
Obesity 1 | 616
Pain agnosia 1 | 99
Paralytic squint 1 | 4
Parkinson's disease 1 | 364
Peripheral Neuropathy 1 | 303
Reperfusion Injury 1 | 84
Status Epilepticus 1 | 85
Stomach Neoplasms 1 | 282
Substance Dependence 1 | 3
Tabes dorsalis 1 | 6
Toxic encephalopathy 1 | 131
Vascular disease 1 | 281
Waldenstrons macroglobulinemia 1 | 765
active Crohn's disease 1 | 918
acute myeloid leukemia 1 | 780
adult high grade glioma 1 | 2,148
aldosterone-producing adenoma 1 | 664
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 499
chronic lymphosyte leukemia 1 | 232
colon cancer 1 | 1,475
dermatomyositis 1 | 933
diabetes mellitus 1 | 1,663
ependymoma 1 | 2,514
fibroadenoma 1 | 557
gastric cancer 1 | 430
gastric carcinoma 1 | 832
hepatocellular carcinoma 1 | 532
inflammatory breast cancer 1 | 404
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
juvenile dermatomyositis 1 | 1,189
lung adenocarcinoma 1 | 2,713
malignant mesothelioma 1 | 3,162
mucosa-associated lymphoid tissue lymphoma 1 | 480
nephrosclerosis 1 | 329
oligodendroglioma 1 | 2,849
osteosarcoma 1 | 7,933
pancreatic carcinoma 1 | 567
pilocytic astrocytoma 1 | 3,086
primary pancreatic ductal adenocarcinoma 1 | 1,271
pterygium 1 | 74
tuberculosis and treatment for 3 months 1 | 327
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Endocrine System 2 | 18,512
Female tissues 2 | 18,647
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Nervous System 2 | 18,561
Respiratory system 2 | 17,484
Skin and soft tissues 2 | 18,115
Urinary Tract 2 | 18,444

Target Family

Non-IDG 1 | 11,971
Transcription Factor 1 | 1,400

Grant Application

5R21AI053428-02 2 | 2
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
SH3 domain-binding protein 5 SH3BP5 Tbio Non-IDG -2.70331 512.0 97
Transcription factor AP-1 JUN Tchem Transcription Factor -3.80760 5981.8 2262